By Jonathan Stempel (Reuters) - A federal judge in Chicago dismissed racketeering claims in a lawsuit accusing Abbott Laboratories and AbbVie Inc of causing health plans to pay unnecessarily for the latter's blockbuster Humira arthritis drug and AndroGel testosterone drug instead of cheaper generics. In a decision on Thursday, U.S. ...
via Health News Headlines - Yahoo News http://ift.tt/Yevfub
No comments:
Post a Comment